Search for a command to run...
Promoters have decreased their stake by 0.32% YoY and 0.04% QoQ, indicating a lack of confidence in the stock compared to static sector averages.
Institutional shareholding remains unchanged, further suggesting a conservative stance amidst broader sector dynamics.
Public shareholding has increased by 2.10% YoY and 6.80% QoQ, but this reactive behavior does not guarantee long-term stability for Jagsonpal Pharmaceuticals.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter7 | 68.71% | 68.48% | 68.09% | 68.04% | 67.97% | 67.81% | 67.77% | 67.65% | |
2Institution | - | - | - | - | - | - | - | - | |
3Public9 | 9.55% | 1.62% | 7.7% | 5.31% | 9.71% | 3% | 9.8% | 9.86% |